Pfizer is taking the next step forward with its vaccine as it applies for emergency FDA approval.

The pharmaceutical company completed its safety review of the much-anticipated COVID-19 vaccine.

Last week, Pfizer announced its vaccine appears to be more than 90% effective.

The FDA advisory committee is set to meet for three days next month and could approve the vaccine as early as the December 10.

FDA authorizes first at-home, rapid COVID test
FDA has issued an emergency use authorization for the first at-home rapid test for COVID-19. The Lucira COVID-19 All-In-One Test Kit is authorized for use at home or point of care in a doctor’s office but only with a prescription. FDA says the molecular test “works by swirling the self-collected sample swab in a vial that is then placed in the test unit. In 30 minutes or less, the results can be read directly from the test unit’s light-up display that shows whether a person is positive or negative for the SARS-CoV-2 virus.”

Regional mask force
Transit agencies in the area are teaming up to encourage riders to wear face coverings. The MTA is partnering with the Port Authority, NJ Transit, Amtrak and SEPTA in the joint effort.

The agencies are forming a regional “mask force” to get more mask compliance and to reduce the risk of COVID-19 spreading to riders and workers.

Courtesy-Abcny7